Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
Clinical trial NCT07490288 · RECRUITING
Trial details
- NCT number
- NCT07490288
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-08
- Primary completion
- 2026-10-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.